List view / Grid view

Paul Ranson (Morgan Lewis)

 

article

EU pharmaceutical regulatory outlook for 2022

22 February 2022 | By

How will a new regulatory landscape impact the EU and UK pharma industries? Early 2022 will see major new clinical trial legislation come into effect, with proposals for an entirely new regulatory regime promised by the end of the year. Paul Ranson, Consultant at Morgan Lewis, reflects on this and…